Phio Pharmaceuticals Corp PHIO shares are trading lower by 40% to $0.95 Thursday afternoon after the company announced it will exercise warrants for $2.8 million in gross proceeds.
Phio Pharmaceuticals announced that accredited investors agreed to exercise certain warrants to purchase over 2 million shares of the company's stock at a reduced price of $1.33 per share, originally issued between 2018 and 2023 at higher prices.
The exercise of these warrants is expected to bring in around $2.8 million in gross proceeds for the company before factoring in fees and expenses.
The shares available for purchase are part of previously registered stock offerings under Form S-1 and Form S-3.
See Also: Phio Pharmaceuticals Announces Exercise of Warrants for $2.8 Million Gross Proceeds
According to data from Benzinga Pro, PHIO has a 52-week high of $12.27 and a 52-week low of $0.88.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
